Titre : Cônes de croissance

Cônes de croissance : Questions médicales fréquentes

Termes MeSH sélectionnés :

Case-Control Studies
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Cônes de croissance : Questions médicales les plus fréquentes", "headline": "Cônes de croissance : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Cônes de croissance : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-08", "dateModified": "2025-04-03", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Cônes de croissance" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Axones", "url": "https://questionsmedicales.fr/mesh/D001369", "about": { "@type": "MedicalCondition", "name": "Axones", "code": { "@type": "MedicalCode", "code": "D001369", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.671.501.145" } } }, "about": { "@type": "MedicalCondition", "name": "Cônes de croissance", "alternateName": "Growth Cones", "code": { "@type": "MedicalCode", "code": "D020439", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Michihiro Igarashi", "url": "https://questionsmedicales.fr/author/Michihiro%20Igarashi", "affiliation": { "@type": "Organization", "name": "Department of Neurochemistry and Molecular Cell Biology, School of Medicine and Graduate School of Medical/Dental Sciences, Niigata University, Niigata, 951-8510, Japan." } }, { "@type": "Person", "name": "Daniel M Suter", "url": "https://questionsmedicales.fr/author/Daniel%20M%20Suter", "affiliation": { "@type": "Organization", "name": "Department of Biological Sciences, Purdue University, West Lafayette, IN, USA. dsuter@purdue.edu." } }, { "@type": "Person", "name": "Yimin Zou", "url": "https://questionsmedicales.fr/author/Yimin%20Zou", "affiliation": { "@type": "Organization", "name": "Neurobiology Section, Biological Sciences Division, University of California San Diego, La Jolla, CA 92093 yzou@ucsd.edu." } }, { "@type": "Person", "name": "Jeffrey van Haren", "url": "https://questionsmedicales.fr/author/Jeffrey%20van%20Haren", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Snehal S Mahadik", "url": "https://questionsmedicales.fr/author/Snehal%20S%20Mahadik", "affiliation": { "@type": "Organization", "name": "Program in Molecular, Cellular, and Developmental Biology, Department of Molecular Biosciences, The University of Kansas, 1200 Sunnyside Avenue, 5049 Haworth Hall, Lawrence, KS 66045." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Risk factors for jaw osteoradionecrosis: a case control study.", "datePublished": "2022-11-11", "url": "https://questionsmedicales.fr/article/36383838", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1590/1807-3107bor-2022.vol36.0132" } }, { "@type": "ScholarlyArticle", "name": "A case-control study on immunologic markers of patients with vitiligo.", "datePublished": "2022-10-14", "url": "https://questionsmedicales.fr/article/36244264", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.biopha.2022.113785" } }, { "@type": "ScholarlyArticle", "name": "Case-Control Study of Long COVID, Sapporo, Japan.", "datePublished": "2023-04-12", "url": "https://questionsmedicales.fr/article/37044126", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3201/eid2905.221349" } }, { "@type": "ScholarlyArticle", "name": "Endothelium-biomarkers for postthrombotic syndrome: a case-control study.", "datePublished": "2023-03-29", "url": "https://questionsmedicales.fr/article/37016998", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/MBC.0000000000001192" } }, { "@type": "ScholarlyArticle", "name": "Risk Factors for Postoperative Pneumonia: A Case-Control Study.", "datePublished": "2022-07-08", "url": "https://questionsmedicales.fr/article/35875004", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fpubh.2022.913897" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Cellules", "item": "https://questionsmedicales.fr/mesh/D002477" }, { "@type": "ListItem", "position": 3, "name": "Neurones", "item": "https://questionsmedicales.fr/mesh/D009474" }, { "@type": "ListItem", "position": 4, "name": "Neurofibres", "item": "https://questionsmedicales.fr/mesh/D009412" }, { "@type": "ListItem", "position": 5, "name": "Axones", "item": "https://questionsmedicales.fr/mesh/D001369" }, { "@type": "ListItem", "position": 6, "name": "Cônes de croissance", "item": "https://questionsmedicales.fr/mesh/D020439" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Cônes de croissance - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Cônes de croissance", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-04", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Cônes de croissance", "description": "Comment identifier un cône de croissance ?\nQuels tests sont utilisés pour étudier les cônes de croissance ?\nLes cônes de croissance peuvent-ils être visualisés in vivo ?\nQuels marqueurs sont utilisés pour les cônes de croissance ?\nPeut-on évaluer la fonction des cônes de croissance ?", "url": "https://questionsmedicales.fr/mesh/D020439?mesh_terms=Case-Control+Studies&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Cônes de croissance", "description": "Quels symptômes indiquent un dysfonctionnement des cônes de croissance ?\nLes cônes de croissance affectent-ils le comportement ?\nComment les cônes de croissance sont-ils liés à la douleur ?\nLes troubles de la croissance neuronale causent-ils des symptômes physiques ?\nLes symptômes neurologiques sont-ils toujours présents avec des cônes de croissance anormaux ?", "url": "https://questionsmedicales.fr/mesh/D020439?mesh_terms=Case-Control+Studies&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Cônes de croissance", "description": "Peut-on prévenir les anomalies des cônes de croissance ?\nQuel rôle joue l'environnement dans le développement des cônes de croissance ?\nLes facteurs génétiques influencent-ils les cônes de croissance ?\nComment le stress maternel impacte-t-il le développement neuronal ?\nLes vaccinations influencent-elles le développement neuronal ?", "url": "https://questionsmedicales.fr/mesh/D020439?mesh_terms=Case-Control+Studies&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Cônes de croissance", "description": "Quels traitements existent pour les troubles liés aux cônes de croissance ?\nLa chirurgie peut-elle corriger des anomalies des cônes de croissance ?\nLes médicaments peuvent-ils aider à la régénération des cônes de croissance ?\nY a-t-il des thérapies innovantes pour les cônes de croissance ?\nComment la réhabilitation aide-t-elle les patients ?", "url": "https://questionsmedicales.fr/mesh/D020439?mesh_terms=Case-Control+Studies&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Cônes de croissance", "description": "Quelles complications peuvent survenir avec des cônes de croissance anormaux ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications neurologiques sont-elles fréquentes ?\nLes complications peuvent-elles être prévenues ?", "url": "https://questionsmedicales.fr/mesh/D020439?mesh_terms=Case-Control+Studies&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Cônes de croissance", "description": "Quels sont les facteurs de risque pour les anomalies des cônes de croissance ?\nLe tabagisme maternel est-il un facteur de risque ?\nL'exposition à des toxines affecte-t-elle les cônes de croissance ?\nLes troubles génétiques augmentent-ils le risque ?\nLe manque de soins prénatals est-il un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D020439?mesh_terms=Case-Control+Studies&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier un cône de croissance ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'observation microscopique des neurones en culture permet d'identifier les cônes de croissance." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour étudier les cônes de croissance ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des techniques comme la microscopie à fluorescence et l'immunohistochimie sont couramment utilisées." } }, { "@type": "Question", "name": "Les cônes de croissance peuvent-ils être visualisés in vivo ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des techniques d'imagerie avancées permettent de visualiser les cônes de croissance in vivo." } }, { "@type": "Question", "name": "Quels marqueurs sont utilisés pour les cônes de croissance ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des marqueurs comme la tubuline et la protéine GAP-43 sont souvent utilisés pour les identifier." } }, { "@type": "Question", "name": "Peut-on évaluer la fonction des cônes de croissance ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests fonctionnels mesurent la capacité des cônes à diriger la croissance axonale." } }, { "@type": "Question", "name": "Quels symptômes indiquent un dysfonctionnement des cônes de croissance ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies dans la croissance neuronale peuvent entraîner des troubles neurologiques." } }, { "@type": "Question", "name": "Les cônes de croissance affectent-ils le comportement ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies dans leur développement peuvent influencer le comportement et les fonctions cognitives." } }, { "@type": "Question", "name": "Comment les cônes de croissance sont-ils liés à la douleur ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des cônes de croissance mal orientés peuvent contribuer à des douleurs neuropathiques." } }, { "@type": "Question", "name": "Les troubles de la croissance neuronale causent-ils des symptômes physiques ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles peuvent entraîner des déficits moteurs ou sensoriels selon la région affectée." } }, { "@type": "Question", "name": "Les symptômes neurologiques sont-ils toujours présents avec des cônes de croissance anormaux ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Pas toujours, mais des anomalies peuvent augmenter le risque de troubles neurologiques." } }, { "@type": "Question", "name": "Peut-on prévenir les anomalies des cônes de croissance ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Certaines anomalies peuvent être évitées par une bonne nutrition et des soins prénatals." } }, { "@type": "Question", "name": "Quel rôle joue l'environnement dans le développement des cônes de croissance ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Un environnement enrichi peut favoriser un développement neuronal sain et fonctionnel." } }, { "@type": "Question", "name": "Les facteurs génétiques influencent-ils les cônes de croissance ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des mutations génétiques peuvent affecter le développement et la fonction des cônes." } }, { "@type": "Question", "name": "Comment le stress maternel impacte-t-il le développement neuronal ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Le stress maternel peut nuire au développement des cônes de croissance et à la santé neuronale." } }, { "@type": "Question", "name": "Les vaccinations influencent-elles le développement neuronal ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccinations ne nuisent pas au développement neuronal et sont essentielles pour la santé." } }, { "@type": "Question", "name": "Quels traitements existent pour les troubles liés aux cônes de croissance ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la thérapie physique, la médication et la rééducation neurologique." } }, { "@type": "Question", "name": "La chirurgie peut-elle corriger des anomalies des cônes de croissance ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Dans certains cas, la chirurgie peut être envisagée pour corriger des malformations structurelles." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider à la régénération des cônes de croissance ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments favorisent la régénération axonale et la plasticité neuronale." } }, { "@type": "Question", "name": "Y a-t-il des thérapies innovantes pour les cônes de croissance ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies géniques et cellulaires sont en cours d'étude pour améliorer la régénération neuronale." } }, { "@type": "Question", "name": "Comment la réhabilitation aide-t-elle les patients ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La réhabilitation aide à restaurer les fonctions perdues et à améliorer la qualité de vie." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des cônes de croissance anormaux ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des troubles neurologiques, des déficits moteurs et des douleurs chroniques." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être atténuées par des traitements précoces et appropriés." } }, { "@type": "Question", "name": "Comment les complications affectent-elles la qualité de vie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent réduire la qualité de vie en limitant les activités quotidiennes." } }, { "@type": "Question", "name": "Les complications neurologiques sont-elles fréquentes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications neurologiques sont courantes chez les patients avec des anomalies des cônes." } }, { "@type": "Question", "name": "Les complications peuvent-elles être prévenues ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être prévenues par un suivi médical régulier et des interventions précoces." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les anomalies des cônes de croissance ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des infections prénatales et des toxines environnementales." } }, { "@type": "Question", "name": "Le tabagisme maternel est-il un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme pendant la grossesse augmente le risque d'anomalies du développement neuronal." } }, { "@type": "Question", "name": "L'exposition à des toxines affecte-t-elle les cônes de croissance ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des toxines environnementales peut nuire au développement neuronal." } }, { "@type": "Question", "name": "Les troubles génétiques augmentent-ils le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains troubles génétiques sont associés à des anomalies dans le développement des cônes." } }, { "@type": "Question", "name": "Le manque de soins prénatals est-il un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un manque de soins prénatals peut augmenter le risque de complications neurologiques." } } ] } ] }

Sources (10000 au total)

Endothelium-biomarkers for postthrombotic syndrome: a case-control study.

The postthrombotic syndrome (PTS) is a long-term complication of deep venous thrombosis (DVT). Increase knowledge on the PTS pathophysiology and novel biomarkers are needed in order to predict PTS dev... A case-control study was conducted. Inclusion criteria were symptomatic and confirmed DVT patients treated with anticoagulants for at least 3 months. Villalta score was performed at the time of inclus... Thirty two patients and 61 controls were included. PTS patients showed higher levels of CEC (0.56/μl (0.34-1.5) vs. 0.20/μl (0.11-0.77); P = 0.04) and EPC (0.75/μl (0.38-1.52) vs. 0.09/μl (0.05-0.82);... The formation and early resolution of DVT are characterized by inflammation and endothelial/platelet activation. We have identified possible novel biomarkers such as CEC, EPC and fractalkine for the d...

Risk Factors for Postoperative Pneumonia: A Case-Control Study.

Postoperative pneumonia is a preventable complication associated with adverse outcomes, that greatly aggravates the medical expenses of patients. The goal of our study is to identify risk factors and ... A matched 1:1 case-control study, including adult patients who underwent surgery between January 2020 and June 2020, was conducted in the Second Affiliated Hospital of Kunming Medical University in Ch... Out of 17,190 surgical patients, 264 (1.54%) experienced postoperative pneumonia. Increased age, chronic obstructive pulmonary disease, emergency surgery, postoperative reduced albumin, prolonged vent... Postoperative pneumonia is associated with severe clinical outcomes. We identified six independent risk factors that can aid in risk stratification and management of patients at risk of postoperative ... www.chictr.org.cn, identifier: chiCTR2100045986....

Significance of temperature in antimuscarinic toxicity: a case-control study.

Antimuscarinic toxicity can result in temperature dysregulation, but the clinical significance of this is unclear. The objective of this study was to compare peak temperatures between antimuscarinic p... This was a case-control analysis at two large, urban, academic medical centers from January 1, 2016, through December 31, 2021. We compared peak temperature (... Fifty-six patients met inclusion criteria of which 23 developed severe outcomes: 16 seizures, 9 cases with hypotension, 5 intubations, and 2 ventricular dysrhythmias. Tmax amongst all patients ranged ... Maximum temperatures did not differ between patients with and without severe outcomes in the setting of antimuscarinic toxicity, and temperature was poorly predictive of outcomes. Our findings suggest...

A postmortem case control study of asbestos burden in lungs of malignant mesothelioma cases.

Asbestos lung content is regarded as the most reliable tool for causal attribution of malignant mesothelioma (MM) to previous asbestos exposures. However, there is a lack of studies on asbestos burden... Asbestos lung content has been assessed on formalin-fixed lung fragments using scanning electron microscopy coupled with energy dispersion spectroscopy (SEM-EDS) on individuals deceased from MM (cases... Asbestos and asbestos bodies (ABs) were found, respectively, in 73.7% and 43.2% of cases and in 28 and 22% of controls; in MM cases the most represented asbestos types were crocidolite and amosite, wh... The results suggest a correlation between asbestos burden in lungs and MM risk. The different concentration of chrysotile, as well as the different width of asbestos fibers in MM males and females mig...

Anemia and Idiopathic Intracranial Hypertension: A Case-Control Study.

Idiopathic intracranial hypertension (IIH) is a condition that mostly affects obese women of childbearing age but has been reported to be temporally related to new diagnoses of anemia. Despite these r... Consecutive IIH patients were recruited from neuro-ophthalmology clinics and matched by age and sex to consecutive patients attending neuro-ophthalmology clinics with diagnoses other than IIH. Complet... One hundred twenty-three IIH patients and 113 controls were included in the study. More IIH patients than controls had anemia (22.8%, 28/123 vs 10.6%, 12/113, P = 0.01) with an odds ratio of 2.48 (95%... Idiopathic intracranial hypertension patients have a higher prevalence of anemia compared with non-IIH neuro-ophthalmology patients. The anemia was mostly mild and may be explained by other factors re...

Study on the association between adverse drug reactions to opioids and gene polymorphisms: a case-case-control study.

Adverse drug reactions (ADRs) caused by opioid drugs show individual differences. Our objective was to explore the association between gene polymorphism and ADRs induced by opioid drugs.... Evidence-based medical data analysis was conducted for genes related to ADRs induced by opioid drugs to select target genes. Sixty patients with cancer pain who had ADRs after taking opioid drugs (mor... Based on a database search and evidence-based medical data, we identified CYP2D6*10, CYP3A5*3, ABCB1, and OPRM1 as target genes for detection. The results of statistical analysis showed no significant... Polymorphism of ABCB1 (062rs1045642) is related to ADRs caused by oxycodone, and the incidence of ADRs is higher with the allele T. Polymorphism of ABCB1 is expected to become a clinical predictor of ...